Genetic test could Fine-Tune TB prevention drug
NCT ID NCT05413551
Summary
This study tested whether using a simple genetic test to guide the dose of a common tuberculosis (TB) prevention drug could make treatment safer and more effective. Researchers gave 73 people at risk for TB different doses of the drug isoniazid based on their genetic results. The goal was to see if personalized dosing helps the body process the drug better, potentially reducing side effects while maintaining protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federal University of Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul, Brazil
Conditions
Explore the condition pages connected to this study.